Statistics from Altmetric.com
Gerbes A, Zoulim F, Tilg H, et al. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut 2018;67:380–388. doi: 10.1136/gutjnl-2017-315068.
Figures 1, 3 and 4 of the above paper were published without acknowledgement of the original source. The legends should include the following information:
Figure 1. Adapted from Kurmann A, Wanner B, Martens F et al. Hepatic steatosis is associated with surgical-site infection after hepatic and colorectal surgery. Surgery 2014;156:109–16. With permission from Elsevier.
Figure 3. Reused from Villanueva A. Rethinking future development of molecular therapies in hepatocellular carcinoma: a bottom-up approach. J Hepatol 2013;59:392–5. With permission from Elsevier.
Figure 4. Adapted from Duffy AG, Ulahannan SV, Makorova-Rusher O et al. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol 2017;66:545–551. With permission from Elsevier.
The publisher apologises for the omission.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.